Related Experiment Videos
Matrix modulation and heart failure: new concepts question old beliefs
Anne M Deschamps1, Francis G Spinale
1Division of Cardiothoracic Surgery, Medical University of South Carolina, Charleston, SC 29403, USA.
Current Opinion in Cardiology
|April 30, 2005
Summary
The extracellular matrix plays a dynamic role in myocardial remodeling, influencing cell behavior in conditions like heart attack and hypertrophy. Understanding these molecular triggers offers new ways to modify adverse cardiac remodeling.
Area of Science:
- Cardiovascular Biology
- Extracellular Matrix Research
- Molecular Cardiology
Background:
- Myocardial remodeling involves complex molecular and cellular factors.
- The extracellular matrix (ECM) is crucial for myocardial structure and cell function.
- Recent research challenges the view of the ECM as a static tissue component.
Purpose of the Study:
- To review recent studies on the dynamic role of the ECM in adverse myocardial remodeling.
- To highlight the ECM's influence on cell behavior beyond structural support.
- To examine the ECM's involvement in conditions like myocardial infarction and hypertrophy.
Main Methods:
- Review of recent scientific literature on myocardial remodeling and ECM.
- Analysis of studies investigating plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs (TIMPs).
- Examination of research on signaling molecules, growth factors, proteases, and structural proteins in left ventricular hypertrophy.
Main Results:
- The ECM's role in myocardial infarction, left ventricular hypertrophy, and dilated cardiomyopathy is increasingly understood.
- Plasma MMP and TIMP profiles serve as surrogate markers for myocardial remodeling.
- Bioactive molecules and proteases significantly influence cell-matrix interactions during left ventricular hypertrophy.
- Modulating TIMP levels directly impacts the myocardial remodeling process.
Conclusions:
- The ECM is an active participant in myocardial remodeling, not just a structural scaffold.
- Understanding cellular and molecular triggers of ECM changes is key to therapeutic interventions.
- Targeting ECM dynamics offers potential strategies to modify adverse cardiac remodeling.